about
Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple SclerosisVaccine approaches for multidrug resistant Gram negative infectionsImmune Adjuvant Effect of Molecularly-defined Toll-Like Receptor LigandsDirecting traffic: IL-17 and IL-22 coordinate pulmonary immune defense.Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccineRecombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?Tailored immune responses: novel effector helper T cell subsets in protective immunity.Antigen-Specific Mammary Inflammation Depends on the Production of IL-17A and IFN-γ by Bovine CD4+ T Lymphocytes.Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c miceCo-Activation of Th17 and Antibody Responses Provides Efficient Protection against Mucosal Infection by Group A Streptococcus.The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responsesIntramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.Trehalose diester glycolipids are superior to the monoesters in binding to Mincle, activation of macrophages in vitro and adjuvant activity in vivoMechanisms of Cholera Toxin in the Modulation of TH17 Responses.Surface-bound bovine serum albumin carrier protein as present in recombinant cytokine preparations amplifies T helper 17 cell polarization.Systemic and local mucosal immune responses induced by orally delivered Bacillus subtilis spore expressing leucine aminopeptidase 2 of Clonorchis sinensis.Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trialSurvey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis.Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection.Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague.Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?Influenza Vaccination and Incident Tuberculosis among Elderly Persons, Taiwan1.Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles.Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.PrtA immunization fails to protect against pulmonary and invasive infection by Streptococcus pneumoniae
P2860
Q26771957-1F6B1857-991E-47C8-8008-D06A8945F0B7Q27007042-DE7FA610-C544-4A78-B132-6915760B7F13Q28972540-90227FA7-4379-4669-B426-CB8E8E90C8D9Q33788735-625915E0-0DA5-4974-A13D-0BDD6C994704Q34531417-99C82FB6-696F-4C0F-9BF7-060764BA5AE3Q34889865-D5E7714E-352D-4315-B087-C7615C9FE833Q35097505-02A59551-DB32-4F60-AF30-AE0E1D4EF14BQ35105613-7259BBB4-9399-43C0-B0CA-C040D8499C49Q35777149-2015968A-597F-4021-B160-F40CDC109579Q36120631-06F5EF78-57EB-4519-9BD9-5133B9DF4410Q36234877-948BAAC4-0D4B-4E9B-B7F3-EBF4699D9793Q36256348-6C617D39-692D-40E5-AE3C-5AA2B99F25E0Q36316792-88F724EE-F795-4829-A131-A6A68ECF9D0BQ37398283-99D7DEFF-BCEA-4014-A6F9-40BB03556CF7Q37641941-07901605-7D19-4EDA-8A26-9E94C041A16EQ39221353-E815D6A5-047D-4645-A620-9B547D37B7ADQ42211666-CE4F20B5-3B47-4CF8-955B-0A2463CDE658Q42376121-8EEF7D4E-D285-494F-A959-0619110E1B68Q43177186-F743FC58-16F1-4670-9F5A-AD49AA0213EBQ47141013-671BCD3D-968E-46E5-B8EB-87151F552AD7Q47163895-1215875D-BA15-494E-85E0-1BD341BE12EDQ47293934-668CF417-3E68-4BA9-8983-FEB13F168804Q47834561-C73AA0C8-BDC4-41D1-9C4E-365A79E7EE8FQ50027368-834B104F-217D-47E0-9F46-153EB00AB683Q50322162-E3E0523A-F9D4-4361-AA72-88D2FF204169Q55432126-9DB9DBBA-B6B7-4A5C-B2FB-C0FF5AF18E9BQ58698200-2D809688-E798-43BA-8FED-27171CA83681
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Th17 cell based vaccines in mucosal immunity.
@en
type
label
Th17 cell based vaccines in mucosal immunity.
@en
prefLabel
Th17 cell based vaccines in mucosal immunity.
@en
P2093
P2860
P1476
Th17 cell based vaccines in mucosal immunity.
@en
P2093
Jay K Kolls
Pawan Kumar
P2860
P304
P356
10.1016/J.COI.2013.03.011
P577
2013-05-10T00:00:00Z